← Back to Search

Educational Messaging for COVID-19 Vaccine Uptake

N/A

Recruiting

Led By Sharon Johnston, MD

Research Sponsored by Hopital Montfort

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Non-vaccinated adults

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 10 months

Awards & highlights

Study Summary

This trial will help to identify the best ways to address vaccine hesitancy and improve uptake of the COVID-19 vaccine.

Who is the study for?

This trial is for non-vaccinated adults in Canada who are enrolled with a family physician participating in the CPIN network. It's not suitable for those who don't speak English or French.Check my eligibility

What is being tested?

The study tests whether tailored digital messages can reduce vaccine hesitancy and increase COVID-19 vaccination rates among patients of family physicians in Ontario, British Columbia, and New Brunswick.See study design

What are the potential side effects?

Since this trial involves communication strategies rather than medical treatments, there are no direct side effects related to drugs or medical interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have not received any vaccinations as an adult.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 10 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~10 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of hesitant individuals who received a COVID-19 vaccine

Secondary outcome measures

Individual willingness to receive a COVID-19 vaccine

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Tailored COVID-19 vaccine messagingExperimental Treatment1 Intervention

Based on the created segments of hesitant participants (reflecting age, language, education level, rurality, sex, gender, ethnicity, and attitudes or reasons for vaccine hesitancy) in the intervention group, a series of tailored messages that are meaningful to the recipients in the different segments will be created and sent to address the factors influencing the willingness to be vaccinated and persuade them to get the COVID-19 vaccine.

Group II: Other health-related messagingActive Control1 Intervention

Patients assigned to the control group will receive health messages unrelated to COVID-19.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Public Health Agency of Canada (PHAC)OTHER_GOV

45 Previous Clinical Trials

89,933 Total Patients Enrolled

Hopital MontfortLead Sponsor

13 Previous Clinical Trials

4,975 Total Patients Enrolled

Eastern Ontario Health UnitUNKNOWN

Media Library

Tailored COVID-19 vaccine messages Clinical Trial Eligibility Overview. Trial Name: NCT04963790 — N/A

Coronavirus Research Study Groups: Tailored COVID-19 vaccine messaging, Other health-related messaging

Coronavirus Clinical Trial 2023: Tailored COVID-19 vaccine messages Highlights & Side Effects. Trial Name: NCT04963790 — N/A

Tailored COVID-19 vaccine messages 2023 Treatment Timeline for Medical Study. Trial Name: NCT04963790 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any new participants currently being enrolled in this study?

"Affirmative. According to clinicaltrials.gov, this experiment is presently seeking participants and has been recruiting since November 14th 2021. The most recent amendments were made on August 23rd 2022. 7200 patients are needed at one specific site for the study to be successful."

Answered by AI

How many participants have been enlisted in this medical trial?

"Affirmative. According to the information housed on clinicaltrials.gov, this research is actively seeking volunteers. It was first posted in mid-November 2021 before being updated most recently on August 23rd 2022 and requires 7200 participants from 1 single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Enabling Family Physicians to Reduce Vaccine Hesitancy and Increase Covid-19 Vaccine Uptake

2021. "Enabling Family Physicians to Reduce Vaccine Hesitancy and Increase Covid-19 Vaccine Uptake". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04963790.

All > Coronavirus